Effectiveness and safety of bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with ST-elevation myocardial infarction

被引：0
|
作者：
Filipa Melao, F. [1 ]
Ribeiro, V. [1 ]
Rodrigues, R. [1 ]
Lopes, R. [1 ]
Pereira, M. [2 ]
Silva, J. C. [1 ]
Maciel, M. J. [1 ]
机构：
[1] Ctr Hosp Sao Joao, Oporto, Portugal
[2] Univ Porto, Sch Med, Dept Hyg & Epidemiol, P-4100 Oporto, Portugal
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2015年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1582
引用
收藏
页码：339 / 339
页数：1
相关论文
共 50 条
  • [31] A comparison of heparin without glycoprotein IIb/IIIa inhibition versus bivalirudin in elective percutaneous coronary intervention
    Gade, Christopher L. F.
    Feldman, Dmitny N.
    Ross, Michael
    Polin, Nichole
    Bergman, Geoffrey
    Wong, S. Chiu
    Minutello, Robert M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : B87 - B87
  • [32] A dual-center analysis of conservative versus liberal glycoprotein IIb-IIIa antagonist strategies in the treatment of ST-elevation myocardial infarction
    Callichurn, Kashi
    Simard, Philippe
    De Marco, Corrado
    Jamali, Payman
    Saada, Yacine
    Matteau, Alexis
    Schampaert, Erick
    Mansour, Samer
    Hatem, Raja
    Potter, Brian J.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [33] Meta-Analysis of Randomized Clinical Trials Comparing Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention and in Patients With ST-Segment Elevation Myocardial Infarction
    Nairooz, Ramez
    Sardar, Partha
    Amin, Hossam
    Swaminathan, Rajesh V.
    Kim, Luke K.
    Chatterjee, Saurav
    Feldman, Dmitriy N.
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (02): : 250 - 259
  • [34] Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplasty
    Bonello, Laurent
    de Labriolle, Axel
    Roy, Probal
    Steinberg, Daniel H.
    Slottow, Tina L. Pinto
    Xue, Zhenyi
    Kaneshige, Kimberly
    Torguson, Rebecca
    Suddath, William O.
    Satler, Lowell F.
    Kent, Kenneth M.
    Pichard, Augusto D.
    Waksman, Ron
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2009, 10 (03) : 156 - 161
  • [35] Enoxaparin versus unfractionated heparin in ST-elevation myocardial infarction - Reply
    Antman, Elliott M.
    Braunwald, Eugene
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (26): : 2831 - 2832
  • [36] Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction
    Antman, EM
    Morrow, DA
    McCabe, CH
    Murphy, SA
    Ruda, M
    Sadowski, Z
    Budaj, A
    López-Sendón, JL
    Guneri, S
    Jiang, F
    White, HD
    Fox, KAA
    Braunwald, E
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (14): : 1477 - 1488
  • [37] HORIZONS in the "Real World": Use of Bivalirudin Versus Heparin plus Glycoprotein IIbIIa Inhibitors in ST Elevation Myocardial Infarction
    Goswami, Nilesh
    Pfeiffer, Amanda
    Moore, Anna
    Mishkel, Greg
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 49I - 49I
  • [38] There a Second Wind for Glycoprotein IIb/IIIa Inhibitors in Elderly Diabetic Females with ST-Elevation Myocardial Infarction, or are We on Thin Ice?
    Timoteo, Ana Teresa
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2021, 116 (02)
  • [39] Upstream/downstream - Glycoprotein IIb/IIIa in Non-ST-segment elevation myocardial infarction
    Ben-Yehuda, O
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (03) : 538 - 540
  • [40] Glycoprotein IIb/IIIa inhibitors and the guidelines for treatment of non-ST-elevation myocardial infarction
    Coplan, NL
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 926 - 927
12345